Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins
- PMID: 1281723
- PMCID: PMC1907914
- DOI: 10.1111/j.1476-5381.1992.tb13392.x
Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins
Abstract
1. We have evaluated the ability of substance P (SP), neurokinin A (NKA) and the selective NK2 receptor agonist [beta-Ala8]-NKA(4-10) to induce superoxide anion (O2-) production and prostanoid (prostaglandin E2, thromboxane B2) release from alveolar macrophages (AMs) isolated from control or actively sensitized guinea-pigs. 2. The dose-response curves for NKA and SP were shifted to the left (three orders and one order of magnitude, respectively) in AMs isolated from sensitized animals, with no variation in maximal effects. 3. By evaluating the effects of [beta-Ala8]-NKA(4-10), we observed that not only was the concentration-response curve shifted to the left in both the functional parameters examined, but also maximal effects were significantly enhanced in AMs isolated from sensitized guinea-pigs. 4. This varied responsiveness seems to be specific for tachykinins, as it was not reproduced by another AM stimulant, the bacterial peptide N-formylmethionyl-leucyl-phenylalanine (fMLP). 5. Only small amounts of beta-glucuronidase were released following tachykinin or ovalbumin stimulation both in control and sensitized AMs. 6. These results indicate that AMs isolated from sensitized guinea-pigs show an increased responsiveness to NK2 receptor stimulation and further stress the role played by AMs in allergic lung diseases.
Similar articles
-
Modulation by protein kinase C of the enhanced responsiveness to tachykinins in ovalbumin-sensitized guinea pig alveolar macrophages.Neuropeptides. 1996 Jun;30(3):249-60. doi: 10.1016/s0143-4179(96)90071-2. Neuropeptides. 1996. PMID: 8819149
-
Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors.Br J Pharmacol. 1990 Jul;100(3):417-20. doi: 10.1111/j.1476-5381.1990.tb15821.x. Br J Pharmacol. 1990. PMID: 1697194 Free PMC article.
-
Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.Br J Pharmacol. 1992 Sep;107(1):27-33. doi: 10.1111/j.1476-5381.1992.tb14459.x. Br J Pharmacol. 1992. PMID: 1384907 Free PMC article.
-
Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study.Neuropeptides. 1996 Oct;30(5):456-64. doi: 10.1016/s0143-4179(96)90010-4. Neuropeptides. 1996. PMID: 8923508
-
Strategies to detect heterologously expressed tachykinin receptors in Xenopus Oocytes.Ann N Y Acad Sci. 1991;632:116-22. doi: 10.1111/j.1749-6632.1991.tb33100.x. Ann N Y Acad Sci. 1991. PMID: 1719860 Review. No abstract available.
Cited by
-
Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs.Br J Pharmacol. 1995 Jan;114(2):259-61. doi: 10.1111/j.1476-5381.1995.tb13220.x. Br J Pharmacol. 1995. PMID: 7881725 Free PMC article.
-
Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs.Br J Pharmacol. 1999 Jun;127(4):1030-8. doi: 10.1038/sj.bjp.0702628. Br J Pharmacol. 1999. PMID: 10433512 Free PMC article.
-
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.J Virol. 2000 Feb;74(4):1614-22. doi: 10.1128/jvi.74.4.1614-1622.2000. J Virol. 2000. PMID: 10644330 Free PMC article.
-
Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.Br J Pharmacol. 2009 Feb;156(3):486-96. doi: 10.1111/j.1476-5381.2008.00033.x. Epub 2009 Jan 16. Br J Pharmacol. 2009. PMID: 19154444 Free PMC article.
-
The role of substance P in myocardial dysfunction during ischemia and reperfusion.Naunyn Schmiedebergs Arch Pharmacol. 1996 Mar;353(4):400-7. doi: 10.1007/BF00261436. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8935706
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources